The first reason I recently suggested for why biotech ML projects often get stuck at the proof-of-concept phase was when the problem you’re solving can’t be acted on.
Wait, are you suggesting that the outcomes should be actionable? That's can't be true...
Wait, are you suggesting that the outcomes should be actionable? That's can't be true...